CYTOSORBENTS CORPORATION (CTSO) Operating margin 2016–2025
CYTOSORBENTS CORPORATION (CTSO) operating margin by fiscal year — reported operating income divided by reported revenue.
-39.8%FY2025 · since FY2016: -120.6% → -39.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -39.8% | +6.4 pp |
| FY2024 | -46.2% | +56.6 pp |
| FY2023 | -102.8% | -11.9 pp |
| FY2022 | -90.9% | -38.2 pp |
| FY2021 | -52.7% | -27.4 pp |
| FY2020 | -25.3% | +50.8 pp |
| FY2019 | -76.0% | -6.8 pp |
| FY2018 | -69.3% | -4.3 pp |
| FY2017 | -65.0% | +55.7 pp |
| FY2016 | -120.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice